US Stock Insider Trading | Zimmer Biomet Holdings Disclosed 13 Company Insider Transactions on March 10

robot
Abstract generation in progress

On March 10, 2026, Zimmer Biomet Holdings (ZBH) disclosed 13 insider transactions. Director Tornos Ivan sold 15,200 shares on March 6, 2026.

[Recent Insider Transactions]

Disclosure Date Position Name Transaction Date Buy/Sell Quantity Price per Share/USD Total Amount/USD
March 10, 2026 Executive Phipps Chad F March 6, 2026 Sell 2,732 92.54 $252,800
March 10, 2026 Executive VAN ZUILEN WILFRED March 6, 2026 Sell 1,822 92.54 $168,600
March 10, 2026 Executive Winkler Lori March 6, 2026 Sell 2,178 92.54 $201,600
March 10, 2026 Executive Stellato Paul A March 6, 2026 Sell 915 92.54 $84,700
March 10, 2026 Executive Upadhyay Suketu March 6, 2026 Sell 6,576 92.54 $608,500
March 10, 2026 Director Tornos Ivan March 6, 2026 Sell 19,200 92.54 $1,776,300
February 27, 2026 Executive Stellato Paul A February 25, 2026 Sell 402 99.51 $40,000
February 27, 2026 Director Tornos Ivan February 25, 2026 Sell 10,600 99.51 $1,050,500
February 27, 2026 Executive VAN ZUILEN WILFRED February 25, 2026 Sell 828 99.51 $8,240
February 27, 2026 Executive Upadhyay Suketu February 25, 2026 Sell 2,832 99.51 $281,800

[Company Profile]

Zimmer Biomet Holdings was incorporated in Delaware in 2001. Its history dates back to 1927 when its predecessor, Zimmer Manufacturing Company, was founded in Warsaw, Indiana. The company is a global leader in medical technology, offering a comprehensive product portfolio aimed at maximizing mobility and improving health. It designs, manufactures, and sells orthopedic reconstruction products; sports medicine, biologics, limb and trauma products; craniofacial and thoracic products; surgical products; and a suite of integrated digital and robotic technologies utilizing data, data analytics, and artificial intelligence.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin